Advertisement

What is new in non-ventilated ICU-acquired pneumonia?

  • Wafa Ibn SaiedEmail author
  • Ignacio Martin-Loeches
  • Jean-François Timsit
What's New in Intensive Care
Guidelines and recommendations for non-ventilated hospital-acquired pneumonia (NV-HAP) are typically based on the research from ventilator-associated pneumonia (VAP) [ 1, 2]. Data for non-ventilated intensive care unit (ICU) patients with nosocomial pneumonia (NV-ICUAP) are scarce (Fig.  1). The current manuscript aims to elucidate whether these conditions are similar or different clinical entities.

Abbreviations

HAP

Hospital-acquired pneumonia

NV-ICUAP

Non-ventilated ICU-acquired pneumonia

VAP

Ventilator-associated pneumonia

Notes

Compliance with ethical standards

Conflicts of interest

The authors declare that they have no conflict of interest.

Supplementary material

134_2019_5859_MOESM1_ESM.pptx (49 kb)
Supplementary material 1 (PPTX 48 kb)

References

  1. 1.
    Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, Timsit JF, Welte T, Wunderink R (2017) International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociacion Latinoamericana del Torax (ALAT). Eur Respir J 50:00582–02017CrossRefGoogle Scholar
  2. 2.
    Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, Napolitano LM, O’Grady NP, Bartlett JG, Carratala J, El Solh AA, Ewig S, Fey PD, File TM Jr, Restrepo MI, Roberts JA, Waterer GW, Cruse P, Knight SL, Brozek JL (2016) Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 63:e61–e111CrossRefGoogle Scholar
  3. 3.
    Giuliano KK, Baker D, Quinn B (2018) The epidemiology of nonventilator hospital-acquired pneumonia in the United States. Am J Infect Control 46:322–327CrossRefGoogle Scholar
  4. 4.
    Ibn Saied W, Mourvillier B, Cohen Y, Ruckly S, Reignier J, Marcotte G, Siami S, Bouadma L, Darmon M, de Montmollin E, Argaud L, Kallel H, Garrouste-Orgeas M, Soufir L, Schwebel C, Souweine B, Glodgran-Toledano D, Papazian L, Timsit JF (2019) A comparison of the mortality risk associated with ventilator-acquired bacterial pneumonia and nonventilator ICU-acquired bacterial pneumonia. Crit Care Med 47:345–352CrossRefGoogle Scholar
  5. 5.
    Mosier JM, Sakles JC, Whitmore SP, Hypes CD, Hallett DK, Hawbaker KE, Snyder LS, Bloom JW (2015) Failed noninvasive positive-pressure ventilation is associated with an increased risk of intubation-related complications. Ann Intensive Care 5:015–0044CrossRefGoogle Scholar
  6. 6.
    Ferrer M, Torres A (2018) Epidemiology of ICU-acquired pneumonia. Curr Opin Crit Care 24:325–331CrossRefGoogle Scholar
  7. 7.
    Weiss E, Zahar J-R, Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Torres A, Wunderink RG, Timsit J-F (2019) Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future hospital-acquired/ventilator-associated bacterial pneumonia clinical trials. Clin Infect Dis 69(11):1912–1918.  https://doi.org/10.1093/cid/ciz093 CrossRefGoogle Scholar
  8. 8.
    Ranzani OT, Senussi T, Idone F, Ceccato A, Li Bassi G, Ferrer M, Torres A (2019) Invasive and non-invasive diagnostic approaches for microbiological diagnosis of hospital-acquired pneumonia. Crit Care 23:019–2348CrossRefGoogle Scholar
  9. 9.
    Russell CD, Koch O, Laurenson IF, O’Shea DT, Sutherland R, Mackintosh CL (2016) Diagnosis and features of hospital-acquired pneumonia: a retrospective cohort study. J Hosp Infect 92:273–279CrossRefGoogle Scholar
  10. 10.
    Chavez MA, Shams N, Ellington LE, Naithani N, Gilman RH, Steinhoff MC, Santosham M, Black RE, Price C, Gross M, Checkley W (2014) Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis. Respir Res 15:1465–9921CrossRefGoogle Scholar
  11. 11.
    Herer B, Fuhrman C, Gazevic Z, Cabrit R, Chouaid C (2009) Management of nosocomial pneumonia on a medical ward: a comparative study of outcomes and costs of invasive procedures. Clin Microbiol Infect 15:165–172CrossRefGoogle Scholar
  12. 12.
    Azoulay E, Mokart D, Lambert J, Lemiale V, Rabbat A, Kouatchet A, Vincent F, Gruson D, Bruneel F, Epinette-Branche G, Lafabrie A, Hamidfar-Roy R, Cracco C, Renard B, Tonnelier JM, Blot F, Chevret S, Schlemmer B (2010) Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 182:1038–1046CrossRefGoogle Scholar
  13. 13.
    Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo LM, Zavala E, Welte T, Torres A (2010) Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am J Respir Crit Care Med 182:1533–1539CrossRefGoogle Scholar
  14. 14.
    Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, Kipnis E, Kollef M, Laupland K, Paiva JA, Rodriguez-Bano J, Ruppe E, Salluh J, Taccone FS, Weiss E, Barbier F (2019) Rationalizing antimicrobial therapy in the ICU: a narrative review. Intensive Care Med 45:172–189CrossRefGoogle Scholar
  15. 15.
    Micek ST, Chew B, Hampton N, Kollef MH (2016) A case-control study assessing the impact of nonventilated hospital-acquired pneumonia on patient outcomes. Chest 150:1008–1014CrossRefGoogle Scholar
  16. 16.
    Shorr AF, Zilberberg MD, Micek ST, Kollef MH (2017) Viruses are prevalent in non-ventilated hospital-acquired pneumonia. Respir Med 122:76–80CrossRefGoogle Scholar
  17. 17.
    Esperatti M, Ferrer M, Giunta V, Ranzani OT, Saucedo LM, Li Bassi G, Blasi F, Rello J, Niederman MS, Torres A (2013) Validation of predictors of adverse outcomes in hospital-acquired pneumonia in the ICU. Crit Care Med 41:2151–2161CrossRefGoogle Scholar
  18. 18.
    Deschepper M, Waegeman W, Eeckloo K, Vogelaers D, Blot S (2018) Effects of chlorhexidine gluconate oral care on hospital mortality: a hospital-wide, observational cohort study. Intensive Care Med 44:1017–1026CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2020

Authors and Affiliations

  • Wafa Ibn Saied
    • 1
    Email author
  • Ignacio Martin-Loeches
    • 2
    • 3
    • 4
  • Jean-François Timsit
    • 1
    • 5
  1. 1.University of Paris, IAME, INSERMParisFrance
  2. 2.Department of Anaesthesia and Critical Care MedicineSt. James’s HospitalDublinIreland
  3. 3.Multidisciplinary Intensive Care Research Organization (MICRO)St James’s HospitalDublinIreland
  4. 4.Pulmonary Intensive Care Unit, Respiratory Institute, Hospital Clinic of Barcelona, IDIBAPSUniversity of BarcelonaBarcelonaSpain
  5. 5.AP-HP, Bichat Hospital, Medical and Infectious Diseases ICU (MI2)ParisFrance

Personalised recommendations